175 related articles for article (PubMed ID: 21777011)
21. New pyrrole inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.
La Regina G; Silvestri R; Artico M; Lavecchia A; Novellino E; Befani O; Turini P; Agostinelli E
J Med Chem; 2007 Mar; 50(5):922-31. PubMed ID: 17256833
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of monoamine oxidase by 8-phenoxymethylcaffeine derivatives.
Okaecwe T; Swanepoel AJ; Petzer A; Bergh JJ; Petzer JP
Bioorg Med Chem; 2012 Jul; 20(14):4336-47. PubMed ID: 22705191
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of monoamine oxidase by 3,4-dihydro-2(1H)-quinolinone derivatives.
Meiring L; Petzer JP; Petzer A
Bioorg Med Chem Lett; 2013 Oct; 23(20):5498-502. PubMed ID: 24012182
[TBL] [Abstract][Full Text] [Related]
24. Novel 4H-1,3,4-oxadiazin-5(6H)-ones with hydrophobic and long alkyl chains: design, synthesis, and bioactive diversity on inhibition of monoamine oxidase, chitin biosynthesis and tumor cell.
Ke SY; Qian XH; Liu FY; Wang N; Yang Q; Li Z
Eur J Med Chem; 2009 May; 44(5):2113-21. PubMed ID: 19027994
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of monoamine oxidase by C5-substituted phthalimide analogues.
Manley-King CI; Bergh JJ; Petzer JP
Bioorg Med Chem; 2011 Aug; 19(16):4829-40. PubMed ID: 21778064
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives.
Legoabe LJ; Petzer A; Petzer JP
Eur J Med Chem; 2012 Mar; 49():343-53. PubMed ID: 22309913
[TBL] [Abstract][Full Text] [Related]
27. A new therapeutic approach in Alzheimer disease: some novel pyrazole derivatives as dual MAO-B inhibitors and antiinflammatory analgesics.
Gökhan-Kelekçi N; Yabanoğlu S; Küpeli E; Salgin U; Ozgen O; Uçar G; Yeşilada E; Kendi E; Yeşilada A; Bilgin AA
Bioorg Med Chem; 2007 Sep; 15(17):5775-86. PubMed ID: 17611112
[TBL] [Abstract][Full Text] [Related]
28. Selected C7-substituted chromone derivatives as monoamine oxidase inhibitors.
Legoabe LJ; Petzer A; Petzer JP
Bioorg Chem; 2012 Dec; 45():1-11. PubMed ID: 23064123
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, and biological activities of pyrrolylethanoneamine derivatives, a novel class of monoamine oxidases inhibitors.
Di Santo R; Costi R; Roux A; Artico M; Befani O; Meninno T; Agostinelli E; Palmegiani P; Turini P; Cirilli R; Ferretti R; Gallinella B; La Torre F
J Med Chem; 2005 Jun; 48(13):4220-3. PubMed ID: 15974574
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and selective human monoamine oxidase B inhibition of heterocyclic hybrids based on hydrazine and thiazole scaffolds.
Carradori S; D'Ascenzio M; De Monte C; Secci D; Yáñez M
Arch Pharm (Weinheim); 2013 Jan; 346(1):17-22. PubMed ID: 23065686
[TBL] [Abstract][Full Text] [Related]
31. Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies.
Karuppasamy M; Mahapatra M; Yabanoglu S; Ucar G; Sinha BN; Basu A; Mishra N; Sharon A; Kulandaivelu U; Jayaprakash V
Bioorg Med Chem; 2010 Mar; 18(5):1875-81. PubMed ID: 20149663
[TBL] [Abstract][Full Text] [Related]
32. Monoamine oxidase isoform-dependent tautomeric influence in the recognition of 3,5-diaryl pyrazole inhibitors.
Chimenti F; Fioravanti R; Bolasco A; Manna F; Chimenti P; Secci D; Befani O; Turini P; Ortuso F; Alcaro S
J Med Chem; 2007 Feb; 50(3):425-8. PubMed ID: 17266193
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives.
Delogu G; Picciau C; Ferino G; Quezada E; Podda G; Uriarte E; Viña D
Eur J Med Chem; 2011 Apr; 46(4):1147-52. PubMed ID: 21316817
[TBL] [Abstract][Full Text] [Related]
34. Structural insights into monoamine oxidase inhibitory potency and selectivity of 7-substituted coumarins from ligand- and target-based approaches.
Catto M; Nicolotti O; Leonetti F; Carotti A; Favia AD; Soto-Otero R; Méndez-Alvarez E; Carotti A
J Med Chem; 2006 Aug; 49(16):4912-25. PubMed ID: 16884303
[TBL] [Abstract][Full Text] [Related]
35. Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Santana L; González-Díaz H; Quezada E; Uriarte E; Yáñez M; Viña D; Orallo F
J Med Chem; 2008 Nov; 51(21):6740-51. PubMed ID: 18834112
[TBL] [Abstract][Full Text] [Related]
36. Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors.
Gaspar A; Silva T; Yáñez M; Vina D; Orallo F; Ortuso F; Uriarte E; Alcaro S; Borges F
J Med Chem; 2011 Jul; 54(14):5165-73. PubMed ID: 21696156
[TBL] [Abstract][Full Text] [Related]
37. Selective inhibition of monoamine oxidase B by aminoethyl substituted benzyl ethers.
Woodroofe CC; Mostashari R; Lu X; Ramsay RR; Silverman RB
J Enzyme Inhib; 2000; 15(1):11-21. PubMed ID: 10850952
[TBL] [Abstract][Full Text] [Related]
38. Novel reversible monoamine oxidase A inhibitors: highly potent and selective 3-(1H-pyrrol-3-yl)-2-oxazolidinones.
Valente S; Tomassi S; Tempera G; Saccoccio S; Agostinelli E; Mai A
J Med Chem; 2011 Dec; 54(23):8228-32. PubMed ID: 22017497
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, stereochemical identification, and selective inhibitory activity against human monoamine oxidase-B of 2-methylcyclohexylidene-(4-arylthiazol-2-yl)hydrazones.
Chimenti F; Maccioni E; Secci D; Bolasco A; Chimenti P; Granese A; Carradori S; Alcaro S; Ortuso F; Yáñez M; Orallo F; Cirilli R; Ferretti R; La Torre F
J Med Chem; 2008 Aug; 51(16):4874-80. PubMed ID: 18666768
[TBL] [Abstract][Full Text] [Related]
40. Indanones as high-potency reversible inhibitors of monoamine oxidase.
Mostert S; Petzer A; Petzer JP
ChemMedChem; 2015 May; 10(5):862-73. PubMed ID: 25820651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
